title: Effects of acute tryptophan depletion on cognitive function in Alzheimer's disease and in the healthy elderly.
abstract: BACKGROUND
  The cholinergic system is profoundly impaired in senile dementia of Alzheimer type (SDAT) and replacement therapy produces only modest clinical benefits. The serotonergic system is also impaired and may contribute both to cognitive and non-cognitive symptoms in SDAT. To investigate this further we assessed the effects of lowering brain serotonin using the technique of acute tryptophan depletion on cognitive function in patients with SDAT and in age matched control subjects.
  
  
  METHODS
  Sixteen patients with probable SDAT and 17 healthy elderly subjects received two amino acid drinks in a within subject, double-blind, placebo-controlled, counterbalanced, crossover design. One of the drinks was nutritionally balanced and contained tryptophan (placebo), the other was identical but contained no tryptophan. A battery of detailed neuropsychological tests was performed between 4 and 6 h after the drink. Mood rating scales and other ratings of behavioural and emotional symptoms were also performed on both occasions.
  
  
  RESULTS
  Acute tryptophan depletion resulted in impairment on tasks of working memory in both groups. There was no group specific effect. Female SDAT subjects performed better on a task of pattern recognition during acute tryptophan depletion compared with placebo. There were no changes in behavioural symptoms during acute tryptophan depletion in either group.
  
  
  CONCLUSIONS
  Compromised serotonergic function may be an important contributor to cognitive decline in SDAT and in ageing. Strategies targeting specific 5HT receptors may be helpful in SDAT.
authors.affiliation: Department of Psychological Medicine, Christchurch School of Medicine, Christchurch, New Zealand.
authors.forename: R J
authors.initials: RJ
authors.lastname: Porter
authors.forename: B S
authors.initials: BS
authors.lastname: Lunn
authors.forename: J T
authors.initials: JT
authors.lastname: O'Brien
mesh_terms: D000339:Affect; D000368:Aged; D000544:Alzheimer Disease / Q000150:complications / Q000523:psychology*; D003072:Cognition Disorders / Q000209:etiology / Q000523:psychology*; D018592:Cross-Over Studies; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D009483:Neuropsychological Tests; D012701:Serotonin / Q000378:metabolism; D013647:Task Performance and Analysis; D014364:Tryptophan / Q000008:administration & dosage / Q000097:blood / Q000172:deficiency*
chemical_list: D012701:Serotonin; D014364:Tryptophan